🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Marex sets price for $600 million senior notes due 2029

Published 10/31/2024, 10:26 PM
MRX
-

NEW YORK - Marex Group plc (NASDAQ:MRX), a global diversified financial services platform, has priced a public offering of $600 million in senior notes with a 6.404% yield, due in 2029. The notes, announced on October 30, 2024, will be sold at par and are expected to be senior unsecured obligations. The offering is slated to close around November 4, 2024, contingent on customary closing conditions.

The company plans to allocate the net proceeds from the offering towards working capital, funding incremental growth, and other general corporate purposes. CEO Ian Lowitt remarked on the strong investor interest in the notes, attributing it to Marex's solid capital and liquidity profile, client-centric business model, and competitive market stance. Specifically, the funds are intended to support the expansion of the company's clearing services and client base.

Barclays, Goldman Sachs & Co. LLC, and Jefferies are serving as joint book-runners and agents for the offering. The transaction is being conducted under Marex's existing shelf registration statement with the U.S. Securities and Exchange Commission (SEC). Interested parties can obtain the preliminary prospectus supplement and accompanying base prospectus through the SEC's website or by contacting the representatives at Barclays, Goldman Sachs, or Jefferies.

This press release does not represent an offer to sell or a solicitation of an offer to buy the notes or any other security, and such an offer or solicitation will not be lawful in jurisdictions where it is unauthorized.

The press release also includes forward-looking statements, which are based on current expectations and projections about future events. These statements are subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those anticipated.

Among the risks cited are potential impacts from geopolitical events, market volatility, regulatory challenges, and changes in the macroeconomic environment. The company acknowledges these risks in the "Risk Factors" section of its preliminary prospectus supplement and other SEC filings.

This news article is based on a press release statement from Marex Group plc.

In other recent news, Marex Group has made significant strides in its strategic growth plans. The global financial services platform has announced public offerings of 8,472,333 and 7 million ordinary shares respectively, led by Barclays, Goldman Sachs & Co. LLC, Jefferies, and Keefe, Bruyette & Woods. Marex has also been active in acquisitions, with Hamilton Court Group, Aarna Capital Limited, and Dropet set to enhance its foreign exchange services, Middle East presence, and entry into the biofuels market respectively.

Citi has maintained its Buy rating on Marex, reflecting confidence in the company's aggressive acquisition strategy and potential for continued expansion. Similarly, Barclays upgraded Marex's stock to Overweight, citing the company's strategic growth potential. These recent developments reflect Marex's commitment to strategic growth and diversification.

It is important to note that all acquisitions are subject to regulatory approvals and other customary closing conditions. The sale and any subsequent purchase of shares will be subject to the registration statement becoming effective in accordance with the relevant securities laws. These updates are based on past articles and analyst notes.

InvestingPro Insights

Marex Group's recent $600 million senior notes offering comes at a time when the company is showing strong financial performance, according to InvestingPro data. With a market capitalization of $1.93 billion, Marex is trading at a relatively modest P/E ratio of 13.56, suggesting potential value for investors.

The company's revenue growth is noteworthy, with a 14.49% increase over the last twelve months as of Q2 2024, reaching $2.08 billion. This growth aligns with Marex's stated intention to use the proceeds from the notes offering for working capital and to fund incremental growth. The company's gross profit margin stands at a robust 67.74%, indicating efficient operations and strong pricing power in its market segments.

InvestingPro Tips highlight Marex's potential:

1. Marex has demonstrated strong revenue growth over the past three years, which supports the company's expansion plans mentioned in the article.

2. The stock is trading near its 52-week high, with the current price at 99.18% of the peak, suggesting investor confidence in the company's prospects.

These insights are just a sample of the valuable information available on InvestingPro. Subscribers can access 13 additional tips for Marex Group, providing a more comprehensive analysis to inform investment decisions.

The company's dividend yield of 2.11% may also attract income-focused investors, complementing the potential for capital appreciation as Marex pursues its growth strategy. With a fair value estimate of $29.08 according to InvestingPro, and analyst targets suggesting a fair value of $30, there may be room for further upside from the current price of $26.55.

As Marex Group moves forward with its capital raise and expansion plans, investors can leverage these InvestingPro insights to better understand the company's financial position and market performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.